FDA Classifies Germ-Fighting Gadget for Safer Labs
Published Date: 6/13/2025
Rule
Summary
The FDA is officially putting a new device called the cellular analysis system for multiplexed antimicrobial susceptibility testing into a special safety category called Class II. This means the device will have clear safety rules to follow, helping it get to patients faster and work better. Labs and companies making or using this device should get ready for these changes, which aim to keep things safe without slowing down innovation.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Device Classified as Class II
The FDA has classified the cellular analysis system for multiplexed antimicrobial susceptibility testing as Class II (special controls). The agency says this classification provides a reasonable assurance of safety and effectiveness and is intended to enhance patients' access to the device by reducing regulatory burdens.
Labs & Makers Should Prepare
Laboratories and companies that make or use the cellular analysis system for multiplexed antimicrobial susceptibility testing should get ready for new special controls that will be codified under the Class II classification. The FDA says these controls aim to keep the device safe without slowing innovation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in